RxSight, Inc. (RXST)
NASDAQ: RXST · IEX Real-Time Price · USD
51.58
+0.91 (1.80%)
At close: Mar 28, 2024, 4:00 PM
53.14
+1.56 (3.02%)
After-hours: Mar 28, 2024, 7:59 PM EDT

RxSight Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Cash & Equivalents
10.412.625.1714.468.83
Short-Term Investments
117.4993.97134.9754.9872.71
Cash & Cash Equivalents
127.89106.56160.1469.4481.54
Cash Growth
20.02%-33.46%130.63%-14.84%-
Receivables
20.2810.964.862.870.79
Inventory
17.4214.848.038.297.22
Other Current Assets
2.812.23.260.910.65
Total Current Assets
168.41134.56176.381.590.2
Property, Plant & Equipment
13.2914.0815.518.6119.25
Other Long-Term Assets
0.861.530.930.570.98
Total Long-Term Assets
14.1415.6116.4319.1820.23
Total Assets
182.55150.16192.72100.68110.43
Accounts Payable
3.862.61.691.132.2
Current Debt
1.81.971.531.270.99
Other Current Liabilities
15.2412.677.869.195.27
Total Current Liabilities
20.917.2411.0811.68.46
Long-Term Debt
1.2143.0343.429.484.53
Other Long-Term Liabilities
0.07003.8374.48
Total Long-Term Liabilities
1.2943.0343.433.3179.01
Total Liabilities
22.1960.2654.4844.9187.46
Total Debt
3.014544.9330.755.52
Debt Growth
-93.31%0.14%46.11%457.51%-
Retained Earnings
-594.64-546.03-479.28-430.59-419.86
Comprehensive Income
-0.01-0.1-0.02-00.05
Shareholders' Equity
160.3689.9138.24-430.59-419.81
Net Cash / Debt
124.8861.57115.2138.6876.02
Net Cash / Debt Growth
102.83%-46.56%197.83%-49.12%-
Net Cash Per Share
3.622.238.466.99-
Working Capital
147.5117.32165.2269.981.74
Book Value Per Share
4.653.2510.15-116.15-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).